30 of the largest PE-backed surgical platforms, ranked by estimated annual revenue lost to cancelled surgical slots.
locations × avg_slots_per_week × cancel_rate × avg_revenue_per_slot × 52 weeks × 60% recovery gap| # | Platform | PE Firm | Specialty Mix | Locations | Est. Annual Leakage | CaseFlow Recovery | |
|---|---|---|---|---|---|---|---|
| 1 |
SCA Health
|
UnitedHealth / Optum | Multi-Specialty ASC, Ortho, GI, Spine | 300 | $198M | $119M | Analyze → |
| 2 |
USPI
|
NMSA / Tenet Healthcare | Orthopedic, GI Endoscopy, Ophthalmology, Spine | 250 | $187M | $112M | Analyze → |
| 3 |
HOPCo
|
WCAS (Welsh, Carson, Anderson & Stowe) | Orthopedic, Spine, Pain Management | 90 | $127M | $76M | Analyze → |
| 4 |
Curalta Health
|
WCAS | Orthopedic, Sports Medicine, Foot & Ankle | 60 | $85M | $51M | Analyze → |
| 5 |
Summit Orthopedics
|
Wealthy | Orthopedic, Spine, Sports Medicine | 45 | $72M | $43M | Analyze → |
| 6 |
Resolve Surgical Solutions
|
WCAS | Orthopedic, Joint Replacement | 55 | $68M | $41M | Analyze → |
| 7 |
Eye Health America
|
WCAS | Ophthalmology, Retina, Cataract | 50 | $64M | $38M | Analyze → |
| 8 |
One GI
|
GTCR | GI Endoscopy, Bariatric | 70 | $62M | $37M | Analyze → |
| 9 |
OrthoFlorida
|
Vitaliate Healthcare | Orthopedic, Spine, Sports Medicine | 50 | $62M | $37M | Analyze → |
| 10 |
Apollo Health
|
GTCR | Ophthalmology, Retina, ASC Multi-Specialty | 55 | $58M | $35M | Analyze → |
| 11 |
CVAUSA
|
WCAS | Cardiology, Peripheral Vascular | 50 | $58M | $35M | Analyze → |
| 12 |
Spire Health
|
WCAS | Orthopedic, Spine, Sports Medicine | 40 | $56M | $34M | Analyze → |
| 13 |
Gastro HealthOne
|
OMERS | GI Endoscopy, Hepatology | 65 | $55M | $33M | Analyze → |
| 14 |
Rula Health
|
KKR | Gastroenterology, Pain Management | 45 | $52M | $31M | Analyze → |
| 15 |
Vivex Biomedical
|
Revelstoke Capital | Pain Management, Orthopedic | 35 | $48M | $29M | Analyze → |
| 16 |
Comprehensive Urological Society
|
NMSA | Urology, BPH, Stone Disease | 48 | $47M | $28M | Analyze → |
| 17 |
Cardiovascular Partners
|
WCAS | Cardiology, Structural Heart | 38 | $46M | $28M | Analyze → |
| 18 |
The Urology Institute
|
Revelstoke Capital | Urology, BPH, Kidney Stone | 40 | $44M | $26M | Analyze → |
| 19 |
ProEx Orthopedics
|
Parform Capital | Orthopedic, Sports Medicine, PT Integration | 42 | $43M | $26M | Analyze → |
| 20 |
StrideCare
|
WCAS | Vascular Surgery, Vein | 35 | $42M | $25M | Analyze → |
| 21 |
Align Ortho
|
Linden Capital Partners | Orthopedic, Sports Medicine | 32 | $41M | $25M | Analyze → |
| 22 |
Skyway Surgical
|
Varsity Healthcare Partners | GI Endoscopy, General Surgery | 38 | $39M | $23M | Analyze → |
| 23 |
Regenexx
|
FTW Partners | Orthopedic, Sports Medicine | 30 | $38M | $23M | Analyze → |
| 24 |
Southern Bone & Joint
|
Lattice Health | Orthopedic, Spine, Pain Management | 28 | $36M | $22M | Analyze → |
| 25 |
NYOS
|
Lattice Health | Orthopedic, Spine, Sports Medicine | 25 | $35M | $21M | Analyze → |
| 26 |
Arise Health (SpineNevada)
|
Worden Capital | Spine, Orthopedic | 25 | $35M | $21M | Analyze → |
| 27 |
Prism Health
|
GTCR | Bariatric, GI Endoscopy, Metabolic | 30 | $34M | $20M | Analyze → |
| 28 |
Midwest Orthopedic Specialty Hospital
|
Shore Capital Partners | Orthopedic, Joint Replacement, Spine | 18 | $32M | $19M | Analyze → |
| 29 |
Atlas Spine
|
Webster Capital | Spine, Orthopedic | 22 | $29M | $17M | Analyze → |
| 30 |
Symbios Medical
|
Shore Capital Partners | Orthopedic, Joint Replacement, Spine | 20 | $27M | $16M | Analyze → |